Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Presidents FY 2024 Budget Request
Draft House and Senate FY24 Labor-HHS-Education Appropriations Bills
Issues: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, emerging special pathogens and public health preparedness programs. Support mandatory funding for public health preparedness. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Support animal research and oppose efforts to increase burden on researchers unnecessarily. Ensure investment in Advanced Research Projects Agency for Health (ARPA-H) does not supplant NIH funding. Oppose arbitrary restrictions on specific types and sites of research. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Social Determinants of Health program (SDOH), Prevention Research Centers, hospital-based and community violence interventions, data modernization, outbreak forecasting, and climate and health, and for research on gun violence. Support funding to combat opioid epidemic. Support ongoing investment in public health infrastructure. Support funding for maternal health. Support expansion of CDC-supported genomic sequencing. Support robust 302(b) allocation. Support funding for Hepatitis-C proposal.

Presidents FY 2024 Budget Request
Draft House and Senate FY24 Commerce - Justice - Science Appropriations Bills
Issue: Support funding for the National Science Foundation.

Presidents FY 2024 Budget Request
HR.4366 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
S.2127 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
Issue: Support funding for the VA medical and prosthetic research program.

Presidents FY 2024 Budget Request
Draft House and Senate FY24 Interior Appropriations Bills
Issue: Support funding for Indian Health Service workforce programs, including graduate medical education partnerships with academic medical centers. Ensure robust non-defense discretionary spending levels. Educate Congress on institutional challenges related to increasing HRSAs oversight of the 340B program and oppose policies requiring covered entities report how they use 340B savings.

S.862 - Restoring Americas Health Care Workforce and Readiness Act
Issue: Support increased funding for the National Health Service Corps, and National Disaster Medical Service (NDMS) demonstration pilot.

Issue: Support increased funding for the National Health Service Corps (NHSC) and Teaching Health Centers.

P.L.118-5 - Fiscal Responsibility Act of 2023
Issue: Oppose cuts to discretionary spending.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Office of Science & Technology Policy (OSTP), Executive Office of the President (EOP), Food & Drug Administration (FDA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

Draft Higher Education Act Reauthorization
Issues: Support affordable income driven repayment plans for borrowers. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF), and elimination of GradPLUS loans.

Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice.

Draft Expanding Medical Education Act
Issue: Support grants to create, expand, and support medical schools and regional medical campuses, including MSIs.

Draft Pathway to Practice Act
Issue: Support Pathway to Practice medical school scholarships and GME positions for underrepresented students.

Draft National Medical Corp Act
Issue: Support improving the pathway from community college to careers in medicine.

Issue: Educate Congress on the role academic medicine can serve with the Commission on the Social Status of Black Men and Boys.

Issue: Support the elimination of taxes on non-tuition student scholarship and grant aid.

Draft Indian Health Service Health Professions Tax Fairness Act of 2023
Issue: Support amending the tax code to make Indian Health Service (IHS) scholarships and loan repayment tax-exempt.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R.3046/S.1403 - Medical Student Education Authorization Act of 2023
Issue: Support grants for primary care training in medically under-resourced communities.

Draft Social Determinants Accelerator Act
Issue: Support grants to address social determinants of health.

Draft Health Equity and Accountability Act
Issue: Support programs to improve health equity and address social determinants of health.

P.L.117-105 - Dr. Lorna Breen Health Care Provider Protection Act
Issue: Implementation of grants directed at improving clinician burnout and well-being.

Draft Pandemic and All-Hazards Preparedness Reauthorization Act and related draft bills
Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels.

Issue: Support authorities to strengthen CDCs and ASPRs ability to prevent and respond to existing and emerging threats.

S.1995 - Public Health Infrastructure Saves Lives Act
Issue: Support investments in core public health infrastructure.

Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers to fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program. Oppose restrictions on covered entities use of contract pharmacy arrangements and the differential treatment of covered entities with respect to reimbursement, participation in standard or preferred networks, and inventory management. Oppose the imposition of additional reporting requirements on 340B hospitals.

H.R.2534 - Preserving Rules Ordered for the Entities Covered Through 340B Act of 2023 (PROTECT 340B Act)
Issue: Support measures to prevent pharmacy benefit managers and commercial insurers from discriminating against 340B covered entities.

H.R.3561 - Promoting Access to Treatments and Extremely Needed Transparency Act of 2023 (PATIENT Act) Issue: Oppose requiring 340B covered entities to report their 340B savings for patients enrolled in Medicaid managed care plans. Oppose implementation of so-called site-neutral payment policies in the Medicare program. Oppose burdensome and duplicative reporting and transparency requirements.

H.R.3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Issue: Impose efforts to impose additional, onerous reporting requirements on 340B hospitals.

Issue: Oppose insurance plans that do not meet Affordable Care Act requirements.

Issue: Support legislation to advance maternal health equity by providing comprehensive coverage during the post-partum period. Support initiatives to ensure robust data collection on maternal health outcomes. Support policies to provide comprehensive and integrated mental health services during the perinatal period.

H.R.2369 - Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023
Issue: Educate Congress on development of Laboratory Developed Tests at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing Food and Drug Administration regulation of the development of Laboratory Developed Tests at academic medical centers.

Issue: Discuss authorization of the Teaching Health Center Graduate Medical Education program.

Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency.

Issue: Provide guidance on the implementation of the No Surprises Act (P.L. 116-260).

Issue: Provide feedback on efforts of the academic medicine community to address climate change and decarbonization.

Issue: Support the nomination of Mandy Cohen to be the CDC Director.

Issue: Express concern regarding actions to inappropriately undermine FDA regulatory authority.

Issue: Seek clarification regarding implementation of the MATE Act within P.L. 117-328.

Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support measures to expand access to mental health and substance use disorder treatment, including increased funding for training on pain management, safe prescribing practices, and substance use disorders, financial incentives to promote the uptake of integrated behavioral health models; and the provision of additional Medicare-supported GME positions for psychiatry and psychiatry sub-specialties.

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, community collaborations, as well as efforts related to GME, workforce, and physician shortages in rural and urban communities, sustainability within the health care sector, and health equity.

Issue: Educate Congress about the financial challenges facing academic medical centers, including reimbursement challenges, workforce challenges, inflation, and others.

Issue: Educate Congress and the administration about the impact of the unwinding of the COVID-19 public health emergency on the academic medicine community and the patients they serve.

Issue: Educate Congress and the administration about medical education on nutrition, hunger, and health; reproductive health; substance use disorders; trans health; preventing fraud and abuse; and diversity, equity, and inclusion.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Natl Capital Planning Commission (NCPC), White House Office, Vice President of the U.S., Drug Enforcement Administration (DEA), Office of Science & Technology Policy (OSTP), Agency for Healthcare Research & Quality (AHRQ), Natl Security Council (NSC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

S.365 - Dream Act of 2023
Issue: Support policies allowing undocumented students to attend U.S. medical schools and graduate medical education.

Draft House Bill/S.665 - Conrad State 30 and Physician Access Reauthorization Act
Issue: Support reauthorization and expansion of the Conrad 30 program, and improvements to physician immigration.

Draft Healthcare Workforce Resilience Act
Issue: Support reduction of green card backlogs for health professionals.

Issue: Support expansion of Medicaid coverage for Deferred Action Childhood Arrivals (DACA) recipients.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

Issue: Educate Congress and the administration about the impact of regulatory burden on medical research.

Issue: Educate Congress and the administration about preparedness and lab safety for pathogens with pandemic potential.

Issue: Urge Congress to work to eliminate Hepatitis- C.

Issue: Support the nomination of Monica Bertagnolli to be NIH Director.

Issue: Support the role of academic medical centers in engaging with ARPA-H.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office, Office of Science & Technology Policy (OSTP), Executive Office of the President (EOP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R.2389/S.1302 - Resident Physician Shortage Reduction Act of 2023
Issue: Support increased Medicare funding for graduate medical education (GME).

H.R.751 - Fair Access in Residency Act
Issue: Oppose legislative interference in residency training program requirements and policies requiring the Medicare program to consider specific physician licensing exams for residency program applications.

S.230/H.R.834 - Rural Physician Workforce Production Act
Issue: Oppose legislation redesigning Medicare GME payment formulas that reduce current DGME/IME payments to teaching hospitals.

Issue: Provide feedback to CMS and Congress on CMS distribution of the 1,000 new GME slots authorized be the Consolidated Appropriations Act, 2021 (P.L. 116-260) as described in the 2022 Inpatient Prospective Payment System (IPPS) proposed rule. Support CMS changing its distribution methodology to end the practice of super prioritization.

Issue: Support Medicare GME per resident amount and cap-setting technical corrections and administrative relief.

Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments.

Issue: Oppose reduction of Medicare GME/IME payments.

Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.

Issue: Oppose establishing nationality-based restrictions on medical residencies supported by Medicare.

Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.

Issue: Oppose site-neutral expansion to excepted off-campus provider-based departments (PBDs).

Issue: Oppose Medicare hospital, physician, and provider cuts.

Issue: Educate Congress on role of academic medicine as it relates to price transparency or disclosure initiatives.

Issue: Protect patients from delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program and providing program oversight and transparency.

Issue: Support necessary changes and improvements to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

Issue: Educate Congress and policymakers on the financial challenges facing teaching hospitals and health systems, medical schools, and faculty practices and the impact on patients access to care and the nations health.

Issue: Support requiring states to extend Medicaid and CHIP coverage during the postpartum period.

Issue: Support delaying or eliminating scheduled cuts to the Medicaid disproportionate share hospital (DSH) program.

H.R.2665 - The Supporting Safety Net Hospitals Act
Issue: Support eliminating two years worth of scheduled reductions to the Medicaid DSH program.

Issue: Support policies to close the Medicaid coverage gap and ensure access to coverage in non-expansion states, as well as financial incentives to help states maintain existing expansions. Support mandatory 12-month Medicaid coverage for post-partum individuals.

Issue: Oppose efforts by states to impose work or other community engagement activities as a requirement for continued Medicaid eligibility or coverage for certain Medicaid beneficiaries.

Issue: Support waiving budget neutrality requirements associated with the E/M code changes or temporarily holding harmless physicians and other health care professionals.

Issue: Support permanent extension of Medicare telehealth waivers, including removing patient location restrictions and rural site requirements, allowing payment for audio-only services, and reimbursing providers for telehealth services as services delivered in-person. Support 2 year or permanent extension of the waivers.

Issue: Support extension of Acute Hospital at Home program waiver of 24/7 nursing requirement.

Issue: Support permanent extension of current Covid telehealth flexibilities.

Issue: Support efforts to expand patient access to telehealth.

H.R.1397 - The Telehealth Improvement for Kids Essential Services Act
Issue: Support providing states with guidance to increase telehealth access in Medicaid and CHIP.

Issue: Support efforts to improve access to childrens mental health care.

Issue: Support increased access to behavioral health and substance use disorder treatment services under Medicare and Medicaid. Support expanded Medicare reimbursement for integrated behavioral health Medicare payment codes. Support the removal of regulatory barriers to telehealth-enabled mental health care, including electronic interprofessional consults (eConsults).

Issue: Support policy to permanently remove requirement for Medicare beneficiaries to be seen in-person every six months for telehealth visits for mental health services.

Issue: Support creation of new Medicare outpatient IME payment in addition to existing Medicare IME payment inpatient methodology. Oppose policies to create IME payments for outpatient services while remaining budget neutral.

Issue: Support efforts to reverse cuts in Medicare OPPS reimbursements to hospitals for drugs acquired under the 340B program.

Issue: Support extension of alternative payment model (APM) bonus.

Issue: Support providing funds for rural teaching hospitals to expand their residency programs.

Issue: Support efforts to investigate nurse-staffing agencies conduct during the COVID-19 pandemic.

H.R.8188/S.4449 - The Saving Access to Laboratory Services (SALSA) Act
Issue: Support legislation to modify Medicare payment rates for clinical diagnostic laboratory services to avoid statutory cuts to these payments.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Issue: support preservation of nonprofit tax status for AAMC member teaching health systems and hospitals with federal nonprofit status.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships.

Issue: Discuss opportunities to support local affiliations between academic medical centers and VA medical centers.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Issue: support preservation of nonprofit tax status for AAMC member teaching health systems and hospitals with federal nonprofit status.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes